MedTrace Logo

Phase II Study for Robot Assisted Distal Gastrectomy

NCT01504997 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2016-11-29

Study results available
· View outcomes & findings →

Summary

The aim of this study is to clarify safety of robot assisted distal gastrectomy with lymph node dissection in patients with stage Ia early gastric cancer.

Conditions

  • Early Gastric Cancer

Interventions

DEVICE

Robot assisted distal gastrectomy (DaVinci)

patients who received robot assisted distal gastrectomy

Sponsors & Collaborators

  • Shizuoka Cancer Center

    lead OTHER

Principal Investigators

  • Masanori Terashima, M.D., Ph.D. · Division of Gastric Surgery, Shizuoka Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-12-31
Completion
2017-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01504997 on ClinicalTrials.gov